Back to search
FDAFDA · Food and drugs·Recall number Z-2654-2026

MEDLINE 111 GRAVITY SET W/3 Needle Free Y-Sites REF DYNDTN0555 Catalog Number: SAM2461 UDI code: N/A Engineering Sample/Not for Human Use

Published July 8, 2026 · Recall initiated: June 4, 2026

Summary

FDA records medical device Class II recall Z-2654-2026, published July 8, 2026 and initiated June 4, 2026. Recalling firm: BD SWITZERLAND SARL; Status: Ongoing; Reported quantity: 50 devices; Lot: Catalog Number: SAM2461 REF: DYNDTN0555 UDI code: N/A Lot Number: 25X445. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Due to engineering sample labeled "Not for Human Use" being inadvertently shipped it the U.S. market.

What to do

Voluntary: Firm initiated

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
BD SWITZERLAND SARL
Distributor
U.S.: IL O.U.S: N/A
Lot
Catalog Number: SAM2461 REF: DYNDTN0555 UDI code: N/A Lot Number: 25X445
Risk classification
Class II
Area (FDA)
device
Country
Switzerland

Related recalls

Questions about this recall

Was MEDLINE 111 GRAVITY SET W/3 Needle Free Y-Sites REF DYNDTN0555 Catalog Number: SAM2461 UDI code: N/A Engineering Sample/Not for Human Use recalled?

Yes. FDA published recall Z-2654-2026 on July 8, 2026. Reported hazard: Due to engineering sample labeled "Not for Human Use" being inadvertently shipped it the U.S. market.

What should I do if I have this product?

Voluntary: Firm initiated